Page last updated: 2024-08-23

azimexon and EHS Tumor

azimexon has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bicker, U; Cortez-Campeao, D; Luckenbach, GA; Modolell, ML; Munder, PG	1

Other Studies

1 other study(ies) available for azimexon and EHS Tumor

Article	Year
Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone). Experimental pathology, 1981, Volume: 19, Issue:1 Topics: Animals; Antibody Formation; Aziridines; Azirines; Bone Marrow; Concanavalin A; Hypersensitivity, Delayed; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Rats; Sarcoma, Experimental	1981

Article

Year

Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone).

Experimental pathology, 1981, Volume: 19, Issue:1

Topics: Animals; Antibody Formation; Aziridines; Azirines; Bone Marrow; Concanavalin A; Hypersensitivity, Delayed; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Rats; Sarcoma, Experimental

1981